OTCMKTS:DOCMF Dr. Martens (DOCMF) Stock Price, News & Analysis $0.89 0.00 (0.00%) As of 10/12/2026 Add Compare Share Share Stock Analysis Stock AnalysisChartNews and Trends About Dr. Martens Stock (OTCMKTS:DOCMF) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get Dr. Martens alerts:Sign Up Key Stats Today's Range$0.89▼$0.8950-Day Range$0.87▼$1.2152-Week Range$0.81▼$1.24VolumeN/AAverage Volume22,751 shsMarket CapitalizationN/AP/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingN/A Company Overview Dr. Martens plc is a British footwear and apparel company best known for its distinctive boots and shoes featuring air-cushioned soles, yellow welt stitching and grooved sides. The company offers a broad range of footwear, including classic lace-up boots, loafers, sandals, casual shoes and platform styles, along with bags, accessories and selected apparel. The brand traces its origins to the development of an air-cushioned sole in Germany in the 1940s. Dr. Martens footwear was first manufactured in the United Kingdom in 1960, and the company’s products later became associated with music, youth culture, fashion and self-expression. Its product portfolio includes both heritage designs and contemporary styles intended for men, women and children. Dr. Martens serves customers internationally through company-operated retail stores, e-commerce platforms and wholesale partners. Its principal markets include the United Kingdom and Europe, North America and the Asia-Pacific region. The company is headquartered in London and, following the planned retirement of longtime chief executive Kenny Wilson, appointed Ijeoma Nwokorie as chief executive officer in 2025.AI Generated. May Contain Errors. Read More Receive DOCMF Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Dr. Martens and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. DOCMF Stock News HeadlinesDr. Martens PLCAugust 1, 2026 | barrons.comDr. Martens strengthens board with appointment of Melanie Richards as senior independent directorJuly 3, 2026 | theglobeandmail.comElon Musk’s One Stock Retirement PlanJeff Brown picked Nvidia in 2016, before it surged 37,000 percent. Now he's tracking a small AI company he says is the same size Nvidia was a decade ago. The company holds 150 patents protecting its core technology, and Brown believes Elon Musk could soon drive major demand for it. A key catalyst is set for November 11. | Brownstone Research (Ad)Dr. Martens PLC (DOCMF) Full Year 2026 Earnings Call Highlights: Strong Profit Growth Amid ...May 28, 2026 | finance.yahoo.comBerenberg Bank Remains a Buy on Dr. Martens Plc (DOCS)May 22, 2026 | theglobeandmail.comDr Martens' turnaround gathers pace as annual profit jumps 61%May 19, 2026 | reuters.comDr. Martens Reshapes Leadership to Drive Consumer‑First GrowthApril 24, 2026 | theglobeandmail.comDr. Martens plc (DRMTY) Q3 2026 Sales/Trading Call TranscriptJanuary 27, 2026 | seekingalpha.comSee More Headlines DOCMF Stock Analysis - Frequently Asked Questions How have DOCMF shares performed this year? Dr. Martens' stock was trading at $1.03 at the beginning of 2026. Since then, DOCMF shares have decreased by 13.2% and is now trading at $0.8939. How do I buy shares of Dr. Martens? Shares of DOCMF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Company Calendar Today10/13/2026Next Earnings (Estimated)11/19/2026Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeOTCMKTS SectorConsumer Discretionary Industry Textiles, Apparel & Luxury Goods Sub-IndustryN/A Current SymbolOTCMKTS:DOCMF CIKN/A Webwww.drmartensplc.com Phone44-12-1415-7047FaxN/AEmployees2,377Year FoundedN/AProfitability EPS (Trailing Twelve Months)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding SharesN/AFree FloatN/AMarket CapN/A OptionableNot Optionable BetaN/A 7 Stocks to Buy Before the Robotics RevolutionRobotics and automation are rapidly becoming essential infrastructure across healthcare, manufacturing, logistics, and many other industries. "Physical AI" is coming. Learn which seven companies are most positioned to benefit as intelligent robots enter the workforce.Get This Free Report This page (OTCMKTS:DOCMF) was last updated on 10/12/2026 by MarketBeat.com Staff. From Our PartnersWall Street legend reveals his top AI stock before Oct. 20Marc Chaikin, the 60-year Wall Street veteran behind the Power Gauge rating system, has flagged a new AI stock...Chaikin Analytics | SponsoredTrump's about to unleash his Midterm WeaponTrump is turning the midterms into a referendum on American energy, pushing for more oil, more gas, and lower ...Monument Traders Alliance | SponsoredA Simple Guide to Options Trading While It's Still FreeA free copy of Options Trading Made Simple is available now but wont stay that way for long. Chris Rowe cal...True Market Insiders | SponsoredThis AI fund posted a 34 percent annualized payout last monthOne small fund tied to artificial intelligence stocks delivered $1,051 in a single month, not through selling ...Investors Alley | SponsoredBuffett's Final Warning: "The Dollar Is Going to Hell"In 2025, the dollar lost 12% in value. Real inflation hit 5%+. 12% + 5% = 17% purchasing power gone. And it's ...Decentralized Masters | SponsoredFederal Reserve Reveals Disturbing New Plan To Control Your MoneyDocket No. OP-1670 is drawing attention for what it reveals about the Federal Reserve's next move. Buried on p...Weiss Ratings | SponsoredWhy major institutions are piling into this digital asset nowBlackRock, JPMorgan, Goldman Sachs, and Fidelity are reportedly accumulating a scarce blockchain asset - one t...Awesomely | SponsoredINSANE DRONE FOOTAGENew drone footage shows a mysterious factory rising at one of Elon Musk's most secure facilities, cleared and ...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Dr. Martens plc Please log in to your account or sign up in order to add this asset to your watchlist. Share Dr. Martens With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free DOCMF Stock Alerts